Menu
Back to User profile » Dr Pengtao Yang
Papers published by Dr Pengtao Yang:
Association Between Genetic Polymorphisms In TYMS And Glioma Risk In Chinese Patients: A Case-Control Study
Yao L, Zhou L, Deng Y, Zheng Y, Yang P, Wang M, Dong S, Hao Q, Xu P, Li N, Wu Y, Zhai Z, Lyu L, Dai Z
OncoTargets and Therapy 2019, 12:8241-8247
Published Date: 7 October 2019
CYP17 polymorphisms are associated with decreased risk of breast cancer in Chinese Han women: a case–control study
Yang P, Wang M, Tian T, Feng Y, Zheng Y, Yang T, Li H, Lin S, Xu P, Deng Y, Hao Q, Li N, Guan F, Dai Z
Cancer Management and Research 2018, 10:1791-1798
Published Date: 3 July 2018
Prognostic role and clinical significance of trophoblast cell surface antigen 2 in various carcinomas
Xu P, Zhao Y, Liu K, Lin S, Liu X, Wang M, Yang P, Tian T, Zhu Y, Dai Z
Cancer Management and Research 2017, 9:821-837
Published Date: 12 December 2017
Prognostic and predictive values of PD-L1 expression in patients with digestive system cancer: a meta-analysis
Dai C, Wang M, Lu J, Dai Z, Lin S, Yang P, Tian T, Liu X, Min WL, Dai Z
OncoTargets and Therapy 2017, 10:3625-3634
Published Date: 21 July 2017
PSCA rs2294008 C > T polymorphism contributes to gastric and bladder cancer risk
Wang M, Wang XJ, Ma YF, Ma XB, Dai ZM, Lv Y, Lin S, Liu XH, Yang PT, Dai ZJ
Therapeutics and Clinical Risk Management 2015, 11:237-245
Published Date: 13 February 2015
Association between MDM2 rs 2279744 polymorphism and breast cancer susceptibility: a meta-analysis based on 9,788 cases and 11,195 controls
Gao J, Kang AJ, Lin S, Dai ZJ, Zhang SQ, Liu D, Zhao Y, Yang PT, Wang M, Wang XJ
Therapeutics and Clinical Risk Management 2014, 10:269-277
Published Date: 15 April 2014